David Arkowitz

Insider Reports History

Entity
Individual
Location
C/O Flexion Therapeutics, Inc., 10 Mall Road, Suite 301, Burlington, MA
Signature
/s/ Marc Banjak, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Arkowitz:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Flexion Therapeutics Inc Chief Financial Officer Common Stock 221K $1.88M $8.50 May 10, 2021 Direct
Seres Therapeutics, Inc. Chief Financial Officer Common Stock 182K $197K $1.08 Feb 16, 2024 Direct
Seres Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 31.9K $43K $1.35 Feb 15, 2024 Direct
Seres Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 288K Feb 14, 2024 Direct
iBio, Inc. Director Stock Option (right to buy) 12.6K Nov 21, 2024 Direct
KINETA, INC./DE Director Stock Option (Right to Buy) 12.5K Sep 4, 2024 Direct
F-star Therapeutics, Inc. Director Common Stock 0 $7.12 Mar 8, 2023 Direct
F-star Therapeutics, Inc. Director Warrant (right to buy) 0 Nov 20, 2020 Direct

Insider Reports Filed by David Arkowitz

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IBIO iBio, Inc. Nov 21, 2024 1 $0 4 Nov 25, 2024 Director
IBIO iBio, Inc. Nov 21, 2024 0 $0 3 Nov 25, 2024 Director
KA KINETA, INC./DE Sep 4, 2024 1 $0 4 Sep 5, 2024 Director
MCRB Seres Therapeutics, Inc. Feb 14, 2024 6 -$4.25K 4 Feb 16, 2024 Chief Financial Officer
MCRB Seres Therapeutics, Inc. Oct 27, 2023 4 -$5.49K 4 Oct 31, 2023 Chief Financial Officer
MCRB Seres Therapeutics, Inc. Apr 27, 2023 1 $0 4 May 1, 2023 Chief Financial Officer
KA KINETA, INC./DE Apr 12, 2023 2 $0 4 Apr 14, 2023 Director
MCRB Seres Therapeutics, Inc. Feb 3, 2023 2 $0 4 Feb 7, 2023 Chief Financial Officer
MCRB Seres Therapeutics, Inc. Jul 5, 2022 1 $200K 4 Jul 6, 2022 Chief Financial Officer
FSTX F-star Therapeutics, Inc. Jun 17, 2022 1 $0 4 Jun 22, 2022 Director
MCRB Seres Therapeutics, Inc. Jun 15, 2022 3 $0 4 Oct 31, 2022 Chief Financial Officer
MCRB Seres Therapeutics, Inc. Feb 4, 2022 1 $0 4 Feb 8, 2022 Executive Vice President, Chief Financial Officer and Head of Business Development
FSTX F-star Therapeutics, Inc. Jun 4, 2021 1 $0 4 Jun 7, 2021 Director
KA YUMANITY THERAPEUTICS, INC. Jun 2, 2021 1 $0 4 Jun 4, 2021 Director
MCRB Seres Therapeutics, Inc. Jun 1, 2021 2 $0 4 Jun 1, 2021 Chief Financial Officer
MCRB Seres Therapeutics, Inc. Jun 1, 2021 0 $0 3 Jun 1, 2021 Chief Financial Officer
FLXN Flexion Therapeutics Inc May 10, 2021 1 -$16.1K 4 May 12, 2021 Chief Financial Officer
FSTX F-star Therapeutics, Inc. Nov 20, 2020 10 -$59.7K 4 Mar 9, 2023 Director